Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexamethasone for prevention of postoperative nausea, vomiting, and pain after laparoscopic ovarian cystectomy
IRCT20200825048515N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of nausea and Severity of vomiting. Started Oct 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on IRCT20200825048515N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N7.